Influx Healthtech MD, chairman, board of directors and AGM
NSE: INFLUXPharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹258.10.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹595 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 20 May 2026
- 28.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 5.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 20 May 2026
- 20.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 30,00080.0% delivered
Influx Healthtech board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- V. B. Goel & Co.Peer-review certificate valid to Mar 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Influx Healthtech AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Influx Healthtech share news and announcements
Annual general meeting, 18 Sep 2026
1,313 shareholders on the register on 11 Sep 2026; present: 3 promoters and 20 others; votes counted by CS Nayan P Pitroda / M/s. PNK & Co..The company's voting result (opens in a new tab)
To consider and adopt the Annual Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026 including the Balance Sheet as on March 31, 2026, the Statement of Profit and Loss and the Cash Flow Statement for the financial year ended on that date and the Reports of the Board of Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.25% · promoters 100.00% · institutions 35.54% · other public 1.12%
- To appoint Mrs. Shirin Munir Ahmed Chandniwala (DIN: 08459623) as a Whole time Director of the Company, who retires by rotation and being eligible offers herself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.25% · promoters 100.00% · institutions 35.54% · other public 1.12%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 1 May 2026, 2 resolutions
1,342 shareholders on the register on 27 Mar 2026; votes counted by CS Nayan P Pitroda / M/s. Pitroda Nayan & Co..The company's voting result (opens in a new tab)
- Alteration in the objects of the Initial Public Offer (“offer”) for which amount was raised.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.74% · promoters 100.00% · institutions 52.99% · other public 0.61%
- Appointment and approval of Sitting Fees of Mr. Mohmad Saleh Mutvalli (DIN: 07361078) as Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.74% · promoters 100.00% · institutions 52.99% · other public 0.61%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines, tax disputes and stakes in unlisted companies
Reported in the filing for the quarter to Jun 2026.
- Unlisted stake heldOLAHEY WELLNESS PRIVATE LIMITEDSince 3 Feb 2026
0.00% bought in the quarter; holding 100.00%, from 100.00%
- Fine or penaltyNational Stock Exchange of India Limited (NSE)Since 30 Jun 2026
Notice issued for alleged non-compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, levying a fine of Rs. 1,45,000 plus applicable GST and calling upon the Company to comply and/or remit the fine within the prescribed timeline.
Alleged non-compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter and Year ended March 31, 2026, resulting in levy of fine by the Exchange.MoreLess
- Tax disputeState Tax Officer and Divison - 8, GujaratSince 13 Aug 2025The Company has preferred an appeal, and the same is currently under process before the appellate authority.At the filing before: Under Process
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Sep 2025. The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesJun 2025 | 48.00 | Funding Capital expenditure requirements for setting up of manufacturing facilities | 36.73 | 4.05 | No |
| Public IssuesJun 2025 | 48.00 | General Corporate Purpose | 6.67 | 5.74 | No |
| Public IssuesJun 2025 | 48.00 | Public Issue Expenses | 5.83 | 5.83 | No |